Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Davis

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Virology|February 6, 2007
Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particlesChad Cecil, Ande West, Martha Collier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2006
Mucosal and systemic adjuvant activity of alphavirus replicon particlesJoseph M Thompson, Alan C Whitmore, Jennifer L Konopka, et al.
Journal of Virology|October 12, 2007
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton ratsHoyin Mok, Sujin Lee, Thomas J Utley, et al.
Vaccine|July 12, 2005
Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660Robert E Johnston, Philip R Johnson, Mary J Connell, et al.
Vaccine|February 23, 2002
Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horsesUdeni B R Balasuriya, Hans W Heidner, Nancy L Davis, et al.
Vaccine|January 17, 2016
Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primatesJohn T Bates, Jennifer A Pickens, Jennifer E Schuster, et al.
IUBMB Life|July 18, 2002
Alphavirus replicon particles as candidate HIV vaccinesNancy L Davis, Ande West, Elizabeth Reap, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Virology|February 6, 2007
Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particlesChad Cecil, Ande West, Martha Collier, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2006
Mucosal and systemic adjuvant activity of alphavirus replicon particlesJoseph M Thompson, Alan C Whitmore, Jennifer L Konopka, et al.
Journal of Virology|October 12, 2007
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton ratsHoyin Mok, Sujin Lee, Thomas J Utley, et al.
Vaccine|July 12, 2005
Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660Robert E Johnston, Philip R Johnson, Mary J Connell, et al.
Vaccine|February 23, 2002
Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horsesUdeni B R Balasuriya, Hans W Heidner, Nancy L Davis, et al.
Vaccine|January 17, 2016
Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primatesJohn T Bates, Jennifer A Pickens, Jennifer E Schuster, et al.
IUBMB Life|July 18, 2002
Alphavirus replicon particles as candidate HIV vaccinesNancy L Davis, Ande West, Elizabeth Reap, et al.
Pageof 3